Carlsbad’s Ionis strikes deal with Japanese pharma worth up to $940M
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...
A Photographer’s Rare Blood Cancer Symptoms Come to Life Through Generative AI
Incyte’s The Unseen Journey illustrates the hidden emotional and physical toll of myeloproliferative neoplasms (MPNs), a ...
Targeted Oncology16h
Next-Generation Approaches and Future Directions in PV Care
A panelist discusses how recent advancements in molecular diagnostics, targeted therapies, and individualized treatment approaches give them greatest optimism for patients with polycythemia vera (PV) ...
Targeted Oncology16h
Advanced Therapeutic Algorithms for PV Treatment Sequencing
A panelist discusses how available therapeutic strategies have enhanced their approach to treatment sequencing in patients with polycythemia vera (PV) by providing a broader armamentarium that allows ...
The American Journal of Managed Care5d
Understanding Hematocrit Thresholds in Polycythemia Vera Treatment
Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for ...